Cover Image
市場調查報告書

Janssen Pharmaceuticals, Inc. - 產品平台分析

Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 309669
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Janssen Pharmaceuticals, Inc. - 產品平台分析 Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014
出版日期: 2014年07月31日 內容資訊: 英文 28 Pages
簡介

Janssen Pharmaceuticals, Inc.是提供配合各種症狀之治療藥的製藥公司。正在製造以過動症(ADHD)為首的綜合內科、心理、神經學、疼痛管理及婦科疾病等領域的治療藥。

本報告提供Janssen Pharmaceuticals, Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Janssen Pharmaceuticals, Inc. 的基本資料

Janssen Pharmaceuticals, Inc. 概要

  • 主要資訊
  • 企業資料

Janssen Pharmaceuticals, Inc. :R&D概要

  • 主要的治療範圍

Janssen Pharmaceuticals, Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Janssen Pharmaceuticals, Inc. :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 藥物研發中的產品/聯合治療模式

Janssen Pharmaceuticals, Inc. :藥物簡介

  • JNJ-56914845
  • ORM-12741
  • DiTU
  • LCTA-949

Janssen Pharmaceuticals, Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Janssen Pharmaceuticals, Inc. :最近的開發平台趨勢

Janssen Pharmaceuticals, Inc. :開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • APD-597

Janssen Pharmaceuticals, Inc. :總公司和子公司的所地

附錄

圖表

目錄
Product Code: GMDHC05791CDB

Summary

Global Markets Direct's, 'Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Janssen Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Janssen Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Janssen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Janssen Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Janssen Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Janssen Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Janssen Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Janssen Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Janssen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Janssen Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Janssen Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Janssen Pharmaceuticals, Inc. Snapshot
    • Janssen Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Janssen Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Janssen Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Janssen Pharmaceuticals, Inc. - Pipeline Products Glance
    • Janssen Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Janssen Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Janssen Pharmaceuticals, Inc. - Drug Profiles
    • JNJ-56914845
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ORM-12741
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DiTU
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LCTA-949
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Janssen Pharmaceuticals, Inc. - Pipeline Analysis
    • Janssen Pharmaceuticals, Inc. - Pipeline Products by Target
    • Janssen Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Janssen Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Janssen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Janssen Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Janssen Pharmaceuticals, Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • APD-597
  • Janssen Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Janssen Pharmaceuticals, Inc., Key Information
  • Janssen Pharmaceuticals, Inc., Key Facts
  • Janssen Pharmaceuticals, Inc. - Pipeline by Indication, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
  • Janssen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
  • Janssen Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014
  • Janssen Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014
  • Janssen Pharmaceuticals, Inc. - Phase II, 2014
  • Janssen Pharmaceuticals, Inc. - Discovery, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Target, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014
  • Janssen Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014
  • Janssen Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014
  • Janssen Pharmaceuticals, Inc., Subsidiaries

List of Figures

  • Janssen Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
  • Janssen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
  • Janssen Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014
  • Janssen Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top